On the question of the interchangeability of monoclonal biosimilar antibodies in the treatment of immune-mediated inflammatory diseases
CommentGastroent Hepatol 2023; 77(1): 34–37. doi: 10.48095/ccgh202334
Literaturepdf Milan Lukáš, Ladislav Šenolt, Spyridon Gkalpakiotis